Transplant Rethink Urged After Brain Tumor Donors Found Safe Transplant Rethink Urged After Brain Tumor Donors Found Safe
The risk for cancer transmission from organ donors with primary brain tumors is lower than previously thought, and organ usage from such donors could be expanded to tackle shortages, say UK researchers.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - March 24, 2023 Category: Transplant Surgery Tags: Hematology-Oncology News Source Type: news
Tempe medical device firm raises $45M to expand technology to treat brain tumors
Tempe-based GT Medical Technologies Inc. raised $45 million to expand its technology to treat patients with operable brain tumors.
The funding will be used to expand the company's commercialization of its GammaTile Therapy, a targeted radiation therapy the U.S. Food and Drug Administration cleared in July 2018 for patients with operable brain tumors, according to GT Medical Technologies.
This series C financing follows a $16 million raise in November 2020 and a $10 million raise in early 2019. … (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - March 24, 2023 Category: Health Management Authors: Angela Gonzales Source Type: news
Man who thought he was short for his age grows 18 inches after doctors remove brain tumour
Jamie Connolly had grown up believing he was small for his age. (Source: Daily Express - Health)
Source: Daily Express - Health - March 22, 2023 Category: Consumer Health News Source Type: news
Cancer Transmission From Organ Donors With Brain Tumors Not Much of a Risk
(MedPage Today) -- Despite concerns about transmission of cancer from deceased organ donors with brain tumors to recipients, results from a cohort study in the U.K. showed that this risk was lower than previously thought.
Among 83 post-transplant... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - March 22, 2023 Category: Neurology Source Type: news
Girl diagnosed with inoperable brain tumour after suffering double vision and migraines
Her family are now fundraising to get Jasmine booked into clinical trials abroad, since they are not available in the UK. (Source: Daily Express - Health)
Source: Daily Express - Health - March 20, 2023 Category: Consumer Health News Source Type: news
Novartis Tafinlar + Mekinist Approved by FDA for Pediatric Patients with BRAF V600E Low-Grade Glioma
New approval based on TADPOLE trial showing overall response rate (ORR) of 47% and median progression-free survival (mPFS) of 20.1 months for Tafinlar + Mekinist compared to 11% ORR and 7.4 months mPFS for standard of care1,2
Approval also... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 19, 2023 Category: Drugs & Pharmacology Source Type: news
Dabrafenib-Trametinib Combo Approved for Pediatric Gliomas Dabrafenib-Trametinib Combo Approved for Pediatric Gliomas
The targeted therapy combination beat chemotherapy on progression-free survival, but there was no difference in overall survival at the interim analysis.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 17, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
Targeted Combination Gets FDA Nod for Pediatric Glioma
(MedPage Today) -- The FDA announced on Thursday that it has approved the BRAF inhibitor dabrafenib (Tafinlar) combined with the MEK inhibitor trametinib (Mekinist) for the treatment of pediatric patients 1 year and older with low-grade glioma... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 17, 2023 Category: American Health Source Type: news
Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma
Novartis today announced the U.S. Food and Drug Administration (FDA) granted approval for Tafinlar® (dabrafenib) + Mekinist® (trametinib) for the treatment of pediatric patients 1 year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation who require systemic therapy. The FDA also approved liquid formulations of Tafinlar and Mekinist, marking the first time a BRAF/MEK inhibitor has been developed in a formulation suitable for patients as young as one year of age. (Source: World Pharma News)
Source: World Pharma News - March 17, 2023 Category: Pharmaceuticals Tags: Featured Novartis Business and Industry Source Type: news
FDA approves dabrafenib with trametinib for pediatric patients with low-grade glioma with a BRAF V600E mutation
On March 16, 2023, the Food and Drug Administration approved dabrafenib (Tafinlar, Novartis) with trametinib (Mekinist, Novartis) for pediatric patients 1 year of age and older with low-grade glioma (LGG) with a BRAF V600E mutation who require systemic therapy. The FDA also approved new oral formula (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - March 16, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Linfield footballer Ross Larkin 'lucky to be alive' after cancer
Northern Ireland under-21 defender Ross Larkin had a brain tumour just before Christmas 2021. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 16, 2023 Category: Consumer Health News Source Type: news
Brain tumour symptoms: Five bizarre cancer warning signs revealed
With more than 120 different types of brain tumours the symptoms are more than just headaches. From hearing voices to excessive growth spurts, there are many signs to look out for. (Source: the Mail online | Health)
Source: the Mail online | Health - March 15, 2023 Category: Consumer Health News Source Type: news
VTE risk low among COVID-19 outpatients
Despite high rates of venous thromboembolism (VTE) in hospitalized COVID-1...Read more on AuntMinnie.comRelated Reading:
Nomogram predicts venous thromboembolism in glioma patients
Disparities found in inferior vena cava filter placement, removal
Alternative method for diagnosing PE as effective as CTPA
CMS releases 2022 Medicare Physician Fee Schedule final rule
New PET/CT tracer effectively targets blood clots (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 14, 2023 Category: Radiology Source Type: news
'I was being treated for bowel cancer - then I found out I'd got a brain tumour'
The patient has spoken after a recent survey revealed three in four people cannot name a single brain tumour symptom. (Source: Daily Express - Health)
Source: Daily Express - Health - March 10, 2023 Category: Consumer Health News Source Type: news
Toddler's rare brain tumour misdiagnosed as a stomach bug - only case in Europe
Little Orla's rare tumour is the only registered case of its kind in the whole of Europe. (Source: Daily Express - Health)
Source: Daily Express - Health - March 9, 2023 Category: Consumer Health News Source Type: news
